dockets: FDA-2024-N-5717
Data license: Public Domain (U.S. Government data) · Data source: U.S. government sources, plus a few identifier registries; each is listed on the methodology page
This data as json
| id | agency_id | title | docket_type | last_modified | object_id | rin | dkabstract | category | subtype | keywords | program | short_title | effective_date | organization | attrs_raw | attr_source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2024-N-5717 | FDA | Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments--Supplemental New Drug Application (sNDA) 218276 S-004 for FABHALTA (iptacopan) Oral Capsules | Nonrulemaking | 2025-02-21T11:50:21Z | 0b00006486867760 | list_pull |
Links from other tables
- 1 row from docket_id in documents